Blastomycosis overview: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
Blastomycosis is a fungal infection caused by the organism ''[[Blastomyces dermatitidis]]''. [[Endemic (epidemiology)|Endemic]] to portions of North America, blastomycosis causes clinical symptoms similar to [[histoplasmosis]].<ref name=Sherris>{{cite book | author = Ryan KJ; Ray CG (editors) | title = Sherris Medical Microbiology | edition = 4th ed. | pages = pp.676&ndash;8 |publisher = McGraw Hill | year = 2004 | id = ISBN 0838585299 }}</ref>
Blastomycosis is a fungal infection caused by the organism ''[[Blastomyces dermatitidis]]''. [[Endemic (epidemiology)|Endemic]] to portions of North America, blastomycosis causes clinical symptoms similar to [[histoplasmosis]].<ref name=Sherris>{{cite book | author = Ryan KJ; Ray CG (editors) | title = Sherris Medical Microbiology | edition = 4th ed. | pages = pp.676&ndash;8 |publisher = McGraw Hill | year = 2004 | id = ISBN 0838585299 }}</ref> Only about half of people who have infection usually develop disease. The symptoms if at all, develop between 3 to 15 weeks after exposure and are similar to a flu like illness. <ref name="www.cdc.gov">{{Cite web  | last =  | first =  | title = CDC - Symptoms of Blastomycosis | url = http://www.cdc.gov/fungal/blastomycosis/symptoms.html | publisher =  | date =  | accessdate = 22 November 2013 }}</ref>


==Historical Perspective==
==Historical Perspective==

Revision as of 17:34, 22 November 2013

Blastomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blastomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blastomycosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blastomycosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Blastomycosis overview

CDC on Blastomycosis overview

Blastomycosis overview in the news

Blogs on Blastomycosis overview

Directions to Hospitals Treating Blastomycosis

Risk calculators and risk factors for Blastomycosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis. Endemic to portions of North America, blastomycosis causes clinical symptoms similar to histoplasmosis.[1] Only about half of people who have infection usually develop disease. The symptoms if at all, develop between 3 to 15 weeks after exposure and are similar to a flu like illness. [2]

Historical Perspective

Blastomycosis was first described by Thomas Casper Gilchrist [2] in 1894 and sometimes goes by the eponym Gilchrist's disease [3]. It is also sometimes referred to as Chicago Disease.

Pathophysiology

Infection occurs by inhalation of the fungus from its natural soil habitat. Once inhaled in the lungs, they multiply and may disseminate through the blood and lymphatics to other organs, including the skin, bone, genitourinary tract, and brain. The incubation period is 30 to 100 days, although infection can be asymptomatic.

Diagnosis

Laboratory Findings

Once suspected, the diagnosis of blastomycosis can usually be confirmed by demonstration of the characteristic broad based budding organisms in sputum or tissues by KOH prep, cytology, or histology.

Treatment

Medical Therapy

Itraconazole given orally is the treatment of choice for most forms of the disease. Cure rates are high, and the treatment over a period of months is usually well tolerated. Amphotericin B is considerably more toxic, and is usually reserved for critically ill patients and those with central nervous system disease.

Primary Prevention

Avoiding travel to areas where the infection is known to occur may help prevent exposure to the fungus, but this may not always be possible.

References

  1. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. pp. pp.676&ndash, 8. ISBN 0838585299.
  2. "CDC - Symptoms of Blastomycosis". Retrieved 22 November 2013.

Template:WS